Span Divergent
Healthcare
524727 BSE
₹26.75
Close ·
- P/E
- Not meaningful: loss-making over the last twelve months
Close 4 Nov 2026 ₹26.75 +3.85 +16.8% 1Y
Start ₹22.90
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures at the close · EPS basis: Consolidated · TTM
- ROCE
- −34.10%
- Debt to Equity
- 0.48
- EPS (TTM)
- −₹4.79
- Book Value
- ₹20.46
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 1.31
- ROE
- −46.30%
- Dividend Yield
- 0.00%
- EBITDA
- −₹1.30 Cr
- 52W High
- ₹51.49
- 52W Low
- ₹20.52
Key Insights
Strengths
2- Stock is trading at 1.07 times its book value
- Debtor days have improved from 45.0 to 32.6 days.
Weaknesses
3- Company has low interest coverage ratio.
- Contingent liabilities of Rs.5.08 Cr.
- Promoter holding has decreased over last 3 years: -15.9%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 7 | 4 | 8 |
| Oscillators | Bearish | 3 | 4 | 2 |
| Moving Averages | Strong Bullish | 4 | 0 | 6 |
Oscillators
Bearish
Bearish
3
Neutral
4
Bullish
2
Overall
Bullish
Bearish
7
Neutral
4
Bullish
8
Moving Averages
Strong Bullish
Bearish
4
Neutral
0
Bullish
6
Key readings
- RSI (14)
- 57.91
- Neutral
- MACD (12,26,9)
- −0.40
- Bullish
- SMA (50)
- 26.73
- Bullish
- SMA (200)
- 28.10
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | Zero base |
|---|---|
| 5Y | +18.40% |
| 3Y | +11.21% |
| 1Y | +92.19% |
| TTM | +171.84% |
Net profit
| 10Y | Turned to loss |
|---|---|
| 5Y | Loss narrowed by ₹3.21 Cr |
| 3Y | Loss narrowed by ₹2.47 Cr |
| 1Y | Loss widened by ₹1.67 Cr |
| TTM | Loss widened by ₹2.26 Cr |
Operating cash flow
| 10Y | Turned positive |
|---|---|
| 5Y | Turned positive |
| 3Y | −51.93% |
| 1Y | −88.17% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | No sales |
|---|---|
| 5Y | +15.29 pp |
| 3Y | −23.77 pp |
| 1Y | −7.73 pp |
| TTM | +7.65 pp |
Revenue by year
| Mar 2017 | ₹2.87 Cr |
|---|---|
| Mar 2018 | ₹14.57 Cr |
| Mar 2019 | ₹24.14 Cr |
| Mar 2020 | ₹9.38 Cr |
| Mar 2021 | ₹7.40 Cr |
| Mar 2022 | ₹13.09 Cr |
| Mar 2023 | ₹12.52 Cr |
| Mar 2024 | ₹12.33 Cr |
| Mar 2025 | ₹8.96 Cr |
| Mar 2026 | ₹17.22 Cr |
Net profit by year
| Mar 2017 | −₹2.61 Cr |
|---|---|
| Mar 2018 | −₹12.50 Cr |
| Mar 2019 | −₹14.05 Cr |
| Mar 2020 | −₹8.61 Cr |
| Mar 2021 | −₹6.16 Cr |
| Mar 2022 | −₹10.15 Cr |
| Mar 2023 | −₹5.42 Cr |
| Mar 2024 | ₹0.79 Cr |
| Mar 2025 | −₹1.28 Cr |
| Mar 2026 | −₹2.95 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.43 | 3.18 | 3.01 | 3.03 | 3.71 | 2.8 | 1.9 | 0.55 | 1.07 | 7.65 | 3.86 | 4.65 | 1.02 |
| Expenses | 2.86 | 2.97 | 2.6 | 2.82 | 3.45 | 2.56 | 2.12 | 1.49 | 1.73 | 7.65 | 4.94 | 5.51 | 2.06 |
| Operating Profit | 0.57 | 0.21 | 0.41 | 0.21 | 0.26 | 0.24 | −0.22 | −0.94 | −0.66 | 0 | −1.08 | −0.86 | −1.04 |
| OPM % | 16.62% | 6.6% | 13.62% | 6.93% | 7.01% | 8.57% | −11.58% | −170.91% | −61.68% | 0% | −27.98% | −18.49% | −101.96% |
| Other Income | 0.18 | 0.27 | 0.36 | 0.96 | 0.2 | 0.25 | 0.47 | 0.34 | 0.91 | 0.22 | 0.34 | 0.15 | 0.28 |
| Interest | 0.19 | 0.18 | 0.18 | 0.17 | 0.16 | 0.15 | 0.14 | 0.15 | 0.12 | 0.12 | 0.11 | 0.12 | 0.14 |
| Depreciation | 0.49 | 0.47 | 0.34 | 0.33 | 0.28 | 0.28 | 0.28 | 0.24 | 0.27 | 0.27 | 0.28 | 0.3 | 0.24 |
| PBT | 0.07 | −0.17 | 0.25 | 0.67 | 0.02 | 0.06 | −0.17 | −0.99 | −0.14 | −0.17 | −1.13 | −1.13 | −1.14 |
| Tax % | −100% | 76.47% | 72% | −32.84% | 550% | 16.67% | 23.53% | 4.04% | 21.43% | 11.76% | 0.88% | −0.88% | 3.51% |
| Net Profit | 0.13 | −0.3 | 0.06 | 0.88 | −0.09 | 0.05 | −0.21 | −1.03 | −0.17 | −0.18 | −1.13 | −1.12 | −1.19 |
| EPS (₹) | 0.37 | −0.48 | 0.22 | 1.68 | −0.02 | 0.24 | −0.27 | −1.63 | −0.18 | −0.24 | −1.78 | −1.32 | −1.45 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 75.47 | 0 | 2.87 | 14.57 | 24.14 | 9.38 | 7.4 | 13.09 | 12.52 | 12.33 | 8.96 | 17.22 | 17.18 |
| Expenses | 74.28 | 5.23 | 8.37 | 25.16 | 31.34 | 15.16 | 9.64 | 12.67 | 11.42 | 10.94 | 9.61 | 19.8 | 20.16 |
| Operating Profit | 1.19 | −5.23 | −5.5 | −10.59 | −7.2 | −5.78 | −2.24 | 0.42 | 1.1 | 1.39 | −0.65 | −2.58 | −2.98 |
| OPM % | 1.58% | — | −191.64% | −72.68% | −29.83% | −61.62% | −30.27% | 3.21% | 8.79% | 11.27% | −7.25% | −14.98% | −17.35% |
| Other Income | 53.94 | 9.98 | 4.04 | 2.57 | −0.76 | 1.96 | 0.82 | −7.54 | −3.45 | 1.77 | 1.25 | 1.28 | 0.99 |
| Interest | 4.39 | 0.03 | 0.2 | 1.7 | 1.89 | 1.99 | 1.58 | 1.08 | 1 | 0.72 | 0.6 | 0.43 | 0.49 |
| Depreciation | 5.96 | 0.18 | 0.82 | 2.6 | 3.62 | 3.45 | 3.11 | 2.17 | 2.17 | 1.64 | 1.09 | 1.17 | 1.09 |
| PBT | 44.78 | 4.54 | −2.48 | −12.32 | −13.47 | −9.26 | −6.11 | −10.37 | −5.52 | 0.8 | −1.09 | −2.9 | −3.57 |
| Tax % | 12.93% | 27.97% | 5.24% | 1.46% | 4.31% | −7.02% | 0.82% | −2.12% | −1.81% | 2.5% | 17.43% | 1.38% | — |
| Net Profit | 38.99 | 3.28 | −2.61 | −12.5 | −14.05 | −8.61 | −6.16 | −10.15 | −5.42 | 0.79 | −1.28 | −2.95 | −3.62 |
| EPS (₹) | 53.59 | 6.06 | −4.78 | −22.89 | −22.28 | −14.23 | −10.23 | −17.94 | −9.25 | 1.79 | −1.68 | −3.44 | −4.79 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.28 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 7.26 |
| Reserves | 54.41 | 44.71 | 43.11 | 30.61 | 19.87 | 12.12 | 6.56 | −3.24 | −8.3 | −7.35 | −8.27 | 7.6 |
| Borrowings | 0.34 | 0.19 | 13.12 | 23.18 | 22.3 | 19.19 | 17.99 | 13.19 | 11.15 | 9.11 | 8.36 | 7.14 |
| Other Liabilities | 3.8 | 0.44 | 2.97 | 4.02 | 1.64 | 2.56 | 4.27 | 12.27 | 17.02 | 16.64 | 17.28 | 6.54 |
| Total Liabilities | 65.83 | 50.8 | 64.66 | 63.27 | 49.27 | 39.33 | 34.28 | 27.68 | 25.33 | 23.86 | 22.83 | 28.54 |
| Fixed Assets | 2.2 | 2.15 | 8.15 | 25.91 | 22.47 | 20.19 | 17.72 | 15.36 | 13.12 | 10.75 | 9.64 | 9.33 |
| CWIP | 0.09 | 0.06 | 10.95 | 0 | 0.06 | 0.13 | 0.02 | 0 | 0 | 0 | 0 | 0 |
| Investments | 45.81 | 35.55 | 27.87 | 25.5 | 16.36 | 10.07 | 9.43 | 4.03 | 3.95 | 4.69 | 6.3 | 5.15 |
| Other Assets | 17.73 | 13.04 | 17.69 | 11.86 | 10.38 | 8.94 | 7.11 | 8.29 | 8.26 | 8.42 | 6.89 | 14.06 |
| Total Assets | 65.83 | 50.8 | 64.66 | 63.27 | 49.27 | 39.33 | 34.28 | 27.68 | 25.33 | 23.86 | 22.83 | 28.54 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 60.91 | −7.36 | −5.38 | −11.74 | −7.09 | −0.12 | −0.21 | 7.03 | 1.98 | 2.5 | 1.86 | 0.22 |
| Investing | −12.13 | 13.39 | −5.55 | 0.81 | 10.05 | 5.89 | 1.99 | −2.05 | 0.53 | 0.12 | −1.05 | 1.55 |
| Financing | −42.19 | −12.17 | 12.74 | 7.37 | −2.82 | −7.32 | −1.41 | −5.5 | −2.3 | −2.09 | −1.15 | 4.12 |
| Net Cash Flow | 6.59 | −6.13 | 1.8 | −3.57 | 0.14 | −1.55 | 0.37 | −0.52 | 0.2 | 0.53 | −0.34 | 5.89 |
| Free Cash Flow | 47.54 | 3.91 | −21.44 | −15.13 | −6.93 | −1.46 | 1.79 | 8.12 | 1.85 | 2.12 | 1.91 | −0.19 |
| CFO/OP | 5,865 | 102 | 13 | 60 | 97 | 0 | 3 | 1,717 | 185 | 183 | −185 | −16 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 3.72 | — | 1.27 | 59.62 | 22.08 | 39.3 | 73.49 | 44.06 | 55.39 | 45.88 | 56.62 | 32.64 |
| Inventory Days | 2.68 | — | 314 | 101 | 52.17 | 83.88 | 143 | 179 | 318 | 206 | 123 | 40.32 |
| Days Payable | 1.17 | — | 78.54 | 39.95 | 12.44 | 79.35 | 298 | 214 | 527 | 480 | 427 | 136 |
| Cash Conversion Cycle | 5.24 | — | 237 | 121 | 61.81 | 43.84 | −81.29 | 9.77 | −154 | −228 | −247 | −63.24 |
| Working Capital Days | −7.01 | — | −706 | −228 | −186 | −311 | −400 | −429 | −600 | −609 | −1,009 | −221 |
| ROCE % | −4.35% | −5.73% | −8.98% | −19.95% | −19.1% | −19.87% | −15.86% | −3.67% | −9.5% | 36.03% | −186.79% | −34.08% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Span Divergent insights
66 extracted metrics across FY11–FY27.
Documents
- 30 May 2015
- General announcements 9 Oct 2026
Frequently Asked Questions about Span Divergent
What does Span Divergent Ltd do?
Incorporated in 1972, Span Divergent Ltd deals in different businesses through various subsidiaries.
Where is Span Divergent Ltd (SDL) listed?
Span Divergent Ltd trades under code 524727 on the BSE.
Which sector does Span Divergent Ltd belong to?
Span Divergent Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the 52-week high and low of Span Divergent Ltd?
Over the last 52 weeks Span Divergent Ltd has traded between ₹20.52 and ₹51.49 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Span Divergent Ltd?
Span Divergent Ltd reported a return on equity of -46.30%. Its debt-to-equity ratio is 0.48.
Company Information
Incorporated in 1972, Span Divergent Ltd deals in different businesses through various subsidiaries.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524727.md for Span Divergent Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.